The Effect of Aerobic Exercise on Nomophobia and Anxiety

Anxiety Disorders Clinical Trial

Official title:

The Effect of Aerobic Exercise on Nomophobia and Anxiety in Nomophobic University Students

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05637658
• Other study ID #: Karataynomofobia
• Status: Completed
• Phase: N/A
• Start date: November 28, 2022
• Est. completion date: January 20, 2023

Study information

• Verified date: November 2022
• Source: KTO Karatay University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

It was aimed to examine the effect of aerobic exercise on nomophobia and anxiety in nomophobic university students.

Description:

It was aimed to examine the effect of aerobic exercise on nomophobia and anxiety in nomophobic university students. There is no study in the literature examining the relationship between aerobic exercise and nomophobia in young people. Since our study will be the first to investigate the subject, we foresee that it is scientifically important and will shed light on future studies. In addition, national or international publications are planned after the study is completed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: January 20, 2023
• Est. primary completion date: December 28, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 24 Years

Eligibility

Inclusion Criteria:

• Individuals who scored above 22 points on the Beck anxiety scale and 60 points or higher on the nomophobia scale

Exclusion Criteria:

• any condition that may prevent the participant from exercising

Related Conditions & MeSH terms

• Anxiety Disorders

Intervention

Other:
• Exercise
aerobic exercise

Locations

Country	Name	City	State
Turkey	KTO Karatay Üniversitesi	Konya

Sponsors (1)

Lead Sponsor	Collaborator
KTO Karatay University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from baseline in nomophobia score at four weeks	The Nomophobia scale, a 7-point Likert scale consisting of 20 questions developed by Yildirim & Correia, was used to evaluate the nomophobia levels of the participants.Those with a total scores less than 20 did not have nomophobia, 21-59 had mild,60-99 had modarate,and 100-140 had extreme nomophobia	baseline and 4 weeks
Secondary	Change from baseline in anxiety score at four weeks	The Beck Anxiety Inventory (BAI), created by Aaron T. Beck and other colleagues, is a 21-question multiple-choice self-report inventory that is used for measuring the severity of anxiety in adolescents and adults ages 17 and older.A maximum of 63 points can be obtained from the scale.Less than 21 points indicates mild anxiety, 22-35 points moderate and above 36 points severe anxiety.	baseline and 4 weeks